Grifols SA
(NASDAQ : GRFS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
-1.03%34.720.9%$1184.62m
JNJJohnson & Johnson
-2.26%128.310.7%$840.00m
MRKMerck & Co., Inc.
-1.08%85.780.6%$774.83m
ABBVAbbVie, Inc.
-0.96%66.872.3%$634.32m
BMYBristol-Myers Squibb Company
-0.46%47.641.4%$633.41m
LLYEli Lilly and Company
-0.45%111.111.0%$421.80m
NVSNovartis AG Sponsored ADR
0.01%89.010.2%$174.34m
AZNAstraZeneca PLC Sponsored ADR
-0.67%45.111.2%$174.24m
GSKGlaxoSmithKline plc Sponsored ADR
0.95%41.370.3%$97.33m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.57%52.400.1%$74.27m
SNYSanofi Sponsored ADR
0.26%42.680.2%$48.85m
LCILannett Company, Inc.
-4.52%6.5536.6%$4.46m
AKTXAkari Therapeutics Plc Sponsored ADR
-1.12%1.761.6%$3.36m
EPIXESSA Pharma Inc
20.56%2.170.1%$0.05m

Company Profile

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.